Mauceri, Helena J <br/><br/>
Everolimus exhibits efficacy as a radiosensitizer in a model of non-small             cell lung cancer.  [electronic resource] 

 -  Oncology reports  May 2012 
 - 1625-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1791-2431 
<br/><br/><label>Standard No.: </label>10.3892/or.2012.1666  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cell Line, Tumor<br/>Combined Modality Therapy<br/>Everolimus<br/>Female<br/>Gene Expression--drug effects<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Mice<br/>Mice, Nude<br/>Phosphorylation--drug effects<br/>Radiation, Ionizing<br/>Radiation-Sensitizing Agents--pharmacology<br/>Ribosomal Protein S6 Kinases, 70-kDa--metabolism<br/>Sirolimus--analogs & derivatives<br/>Xenograft Model Antitumor Assays